Virology/Bacterial/Genetic Testing Services provided by Micropathology Ltd

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-065b23-2026-04-01T13:16:50+01:00",
    "date": "2026-04-01T13:16:50+01:00",
    "ocid": "ocds-h6vhtk-065b23",
    "description": "This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to decision makers by Friday 6th March 2026.<br/>Decision Makers include:<br/>Sarah Brown<br/>Jonathan Lewis<br/><br/>When applying the 5 key criteria to this provision, GHFT applied the following:<br/><br/><br/>* Quality and Innovation (30%)<br/>Due to working with this provider for several years, they have proven to provide quality testing and reporting for GHFT patients and have been able to ensure future care planning can be implemented. <br/>* Value (25%)<br/>Due to the capacity demands, GHFT are unable to meet all pathology needs and therefore outsourcing activity is a must to be able to keep up with demand. This is a cost and volume contract so GHFT only pay for the tests that are requested and as the contract is for send away testing, it also ensures that testing is easily accessible for patients and reporting has a quick turnaround to ensure patient care can be appropriately planned. <br/>* Integration, Collaboration and Service Sustainability (15%)<br/>Micropathology Ltd are a well-established provider of virology/bacterial requests by PCR/serology/sequencing reporting. GHFT has a positive working relationship and work collaboratively to provide testing/reporting needs for patients. <br/><br/>* Improving Access (20%)<br/>Due to being send away tests, GHFT can access the required testing/reporting needs quickly and will therefore allow testing to be accessible for all and improves health inequalities. <br/>* Social Value (15%)<br/>Being able to contract for this support allows patients to access services quickly. Due to being send away tests, patients are not required to attend any further clinics and as well as not having to attend additional appointments to access services. <br/>There were no conflicts of interests declared.",
    "initiationType": "tender",
    "tender": {
        "id": "ocds-h6vhtk-065b23",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "Virology/Bacterial/Genetic Testing Services provided by Micropathology Ltd",
        "status": "complete",
        "classification": {
            "scheme": "CPV",
            "id": "85111800",
            "description": "Pathology services"
        },
        "mainProcurementCategory": "services",
        "description": "This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. This contract has now been formally awarded using direct award process C. <br/>The contract has been awarded on 09.03.2026 with the indicative contract value is PS123,000 for the 3 year contract<br/>There were no reviews during the standstill period. <br/>No conflicts or potential conflicts of interest recorded.",
        "lots": [
            {
                "id": "1",
                "description": "Micropathology Ltd provide GHFT a testing service for virology/bacterial request by PCR/serology/sequencing and the reporting of these results.<br/><br/>GHFT are intending to award a contract to Mircropathology Ltd who is the existing provider, by following Direct Award C of the PSR<br/>The approximate lifetime value of the contract is PS123,000<br/>The contract covers 08.09.2025 until 07.09.2028",
                "awardCriteria": {
                    "criteria": [
                        {
                            "type": "price"
                        }
                    ]
                },
                "hasOptions": false,
                "status": "cancelled"
            }
        ],
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "85111800",
                        "description": "Pathology services"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UKK13"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "procurementMethod": "limited",
        "procurementMethodDetails": "Award procedure without prior publication of a call for competition",
        "procurementMethodRationaleClassifications": [
            {
                "id": "D_OUTSIDE_SCOPE",
                "scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
                "description": "The procurement falls outside the scope of application of the directive"
            }
        ],
        "procurementMethodRationale": "This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to the relevant authority by Friday 6th March 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under PSR.",
        "amendments": [
            {
                "id": "1",
                "description": "This is a Provider Selection Regime (PSR) confirmation of award notice. The contract has been awarded under the Health Care Services (Provider Selection Regime) 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 or Procurement Act 2023, do not apply to this award. This contract has now been formally awarded to Direct Award C.The contract was awarded on the 24.02.2026 and the service is intended to be provided between the 08.09.2025 until 07.09.2028The indicative contract value for this contract is PS123,000 for the lifetime of the contract. There was an 8 day standstill period as per PSR guidance and the persons involved in the final award decision is as follows:Jonathan Lewis, GHFT Laboratory Manager Sheila Byrne, GHFT Deputy Laboratory ManagerThere were no conflicts of Interest declared throughout the process."
            }
        ]
    },
    "awards": [
        {
            "id": "016516-2026-1",
            "relatedLots": [
                "1"
            ],
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-175291",
                    "name": "Micropathology Limited"
                }
            ]
        }
    ],
    "parties": [
        {
            "id": "GB-FTS-76446",
            "name": "Gloucestershire Hospitals NHS Foundation Trust",
            "identifier": {
                "legalName": "Gloucestershire Hospitals NHS Foundation Trust"
            },
            "address": {
                "streetAddress": "Alexandra House, Cheltenham General Hospital, Sandford Road",
                "locality": "Gloucester",
                "region": "UKK1",
                "postalCode": "GL53 7AN",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "name": "Kelly Attwood",
                "email": "kattwood@nhs.net"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://www.gloshospitals.nhs.uk/",
                "buyerProfile": "https://www.gloshospitals.nhs.uk/",
                "classifications": [
                    {
                        "id": "BODY_PUBLIC",
                        "scheme": "TED_CA_TYPE",
                        "description": "Body governed by public law"
                    },
                    {
                        "id": "07",
                        "scheme": "COFOG",
                        "description": "Health"
                    }
                ]
            }
        },
        {
            "id": "GB-FTS-175291",
            "name": "Micropathology Limited",
            "identifier": {
                "legalName": "Micropathology Limited",
                "id": "03022426"
            },
            "address": {
                "streetAddress": "The Venture Centre, Sir William Lyons Road, University of Warwick Science Park, Coventry, CV4 7EZ",
                "locality": "Coventry",
                "region": "UKG13",
                "postalCode": "CV4 7EZ",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "email": "info@micropathology.com"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "url": "http://www.micropathology.com",
                "scale": "sme"
            }
        }
    ],
    "buyer": {
        "id": "GB-FTS-76446",
        "name": "Gloucestershire Hospitals NHS Foundation Trust"
    },
    "contracts": [
        {
            "id": "016516-2026-1",
            "awardID": "016516-2026-1",
            "status": "active",
            "value": {
                "amount": 123000,
                "currency": "GBP"
            },
            "dateSigned": "2026-02-24T00:00:00Z"
        }
    ],
    "bids": {
        "statistics": [
            {
                "id": "1",
                "measure": "bids",
                "relatedLot": "1",
                "value": 1
            }
        ]
    },
    "language": "en"
}